Inogen to Present at Upcoming Investor Conferences
Get Alerts INGN Hot Sheet
Join SI Premium – FREE
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences:
- Stifel 2024 Healthcare Conference on Monday, November 18 at 9:10 a.m. Eastern Time
- Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4 at 10:30 a.m. Eastern Time
A live audio webcast and archived recording of each presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
About Inogen
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.
For more information, please visit www.inogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104797674/en/
Source: Inogen, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Whale Materials Names Jack Johnson Chief Executive Officer to Lead Next Phase of Commercial Growth
- Arango Recognized as a Strong Performer in Multimodel Data Platforms, Q2 2026 Evaluation
- MONTEFIORE EINSTEIN INVESTIGATORS DEMONSTRATE HOW A NEW SETTING FOR A DIGITAL MONITORING DEVICE CAN TRANSFORM DIABETES CARE
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share